Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Strong Q1 Financial Results Driven by Cystic Fibrosis Treatment Growth
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameVertex Pharmaceuticals Incorporated
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









